The 5th Circuit Says a Houston Cop Reasonably Killed 2 Innocent People Falsely Accused of Selling Heroin
The officer's avowed reasons for killing Dennis Tuttle and Rhogena Nicholas were contradicted by the physical evidence.
The officer's avowed reasons for killing Dennis Tuttle and Rhogena Nicholas were contradicted by the physical evidence.
Aaron Brown discusses how research gets distorted, why sensational claims spread so quickly, and how to think more critically about the numbers behind the headlines.
A dispensary owner believes Hawaii’s hemp regulations are unconstitutional. He’s suing to stop their enforcement, but the law may not be on his side.
Rescheduling marijuana will make it easier to study a drug that tens of millions of Americans already use.
The Supreme Court's decision in United States v. Hemani could open the door to relief for cannabis consumers convicted of illegal gun possession.
The decision is a modest but welcome step toward rectifying the injustice of criminalizing conduct that violates no one’s rights.
Even under the Supreme Court's highly elastic understanding of that clause, Thomas says, such laws do not qualify as regulation of interstate commerce.
How Trump rebranded the war on drugs as a fight against illegal immigration
The conservative justice continues to wage a lonely legal crusade over the Commerce Clause.
Here are the sketchy tactics California’s public health agency is using to convince towns and cities to ban tobacco sales.
The Supreme Court's unanimous decision in Hemani.
The unanimous decision upholding the gun rights of cannabis consumers is striking given the Supreme Court's long history of accommodating the war on drugs.
A notable 9-0 Second Amendment decision that features three concurring opinions, all of which make good points.
A landmark win for the right to keep and bear arms in United States v. Hemani.
After nearly four years of legal battles, Tayvin Galanakis has finally won his case against the officers who arrested him for allegedly driving while intoxicated without probable cause.
State health officials scouted towns, scripted hearings, recruited teen witnesses, and celebrated each ban as a "win."
Federal prohibition of hemp-derived THC products would destroy a $37.5 billion industry to solve a problem states are already handling.
With cigarettes costing around $40 a pack, Australia’s war on smoking has become a case study in how prohibitionist policies create black markets, violence, and criminal power.
But many older enhanced athletes did achieve better results than their younger selves.
After nine months of murdering suspected cocaine smugglers, the Trump administration has no evidence that the strategy is working as advertised.
Alvin Roth, Nobel Memorial Prize–winning economist, wants us to think more about how controversial freedoms can become commonplace.
Nobel Prize-winning economist Alvin E. Roth discusses the moral limits of markets, how bans create black markets, and why harm reduction often works better than prohibition.
I watched hours and hours of the Enhanced Games so you didn’t have to.
Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.
A 10 percent ownership cap was supposed to prevent monopolies in Missouri's marijuana market. Instead, the state's licensing regime may have created a blueprint for companies to build one.
The mother is suing after she delivered her preterm baby on the jail's floor following 24 hours of labor with no medical assistance.
The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Sen. John Fetterman discusses the state of the Democratic Party, immigration, foreign policy, and the dangers of political extremism.
Nominees include stories on America's gerontocracy, the war on chocolate, how Texas beat California on housing, and more.
On the subject of tobacco harm reduction, the former commissioner let his emotions override his avowed commitment to following the science.
Terminally ill patients were promised access to experimental treatments, but the "right to try" exists mostly on paper.
The civil liberties group, which long maintained that there is no constitutional right to arms, sang a different tune at the Supreme Court this year.
Plus: Ella Emhoff's SSRIs, measuring childhood independence, the hantavirus cruise ship, and more...
Plus: The NFL has no easy response to the Dianna Russini–Mike Vrabel affair, and how ketamine may have helped the Sixers upset the Celtics
Nicole Saphier seems determined to obscure the health advantages of a much less hazardous alternative to cigarettes.
Making less harmful products harder to get pushes people toward more dangerous ones.
The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
To justify punishing a legislator for his speech, a FIRE brief notes, Defense Secretary Pete Hegseth relies on a Supreme Court precedent that is clearly inapposite.
Plus: California fails to unmask ICE agents, the illogic of medical-only marijuana rescheduling, driverless cars in D.C., and more...
Acting Attorney General Todd Blanche's distinction between medical and recreational cannabis is hard to reconcile with the relevant scientific and statutory criteria.
Plus: skyway socialism, reconsider the lobster, D.C.'s urban growth, and more...
With smoking rates already declining, the infantilization of future adults is unlikely to be a big win for public health.
The medical model assumes that people should be allowed to use psychedelics only for government-approved reasons.
Donald Trump is an unlikely but powerful champion of drug reform.
Real medical freedom will require something greater than replacing the public health establishment: ending the FDA's monopoly.
Plus: Scandal at the Department of Labor, the real reasons people use psychedelics, more problems with Trump's triumphal arch, and more...
Plus: Trump orders psychedelic drug research, Palantir calls for national service, and confusion surrounds Iran and the Strait of Hormuz.
The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?
New from Reason: a look into what Javier Milei has accomplished and what it will take to make the most of Argentina’s window for real change. Out now for subscribers.